Chronicle Journal: Finance

Sen. Grassley says probe of 'secretive' drug industry pricing won't stop with drugmakers

Senate Finance Committee Chairman Chuck Grassley said there needs to be more transparency into how drug prices are set, a system which he said seems to be "a great deal of secrecy."
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.